MLKMFOTCPerfumes, Cosmetics & Other Toilet PreparationsAlso trades as MLKWF
Waldencast plc
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 13, 2026
$0.88−0.01 (-0.92%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Waldencast plc revenue by segment
By business segment
| Revenue | FY2025 | FY2024 | FY2023 | FY2021 | FY2020 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|
| Obagi Medical | $161.63M | $149.27M | $117.65M | – | – | 59.4% | +8.3% |
| Milk Makeup | $110.44M | $124.60M | $100.49M | $142.47M | – | 40.6% | -11.4% |
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2021 | FY2020 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|
| Net product sales | $268.18M | $269.37M | $213.12M | $136.76M | $88.52M | 98.6% | -0.4% |
| Royalties | $3.89M | $4.50M | $5.02M | $5.71M | $5.90M | 1.4% | -13.6% |
By region
From the segment and revenue-disaggregation notes of Waldencast's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.